Cargando…
Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure
Heart failure (HF) is associated to endothelial dysfunction that promotes the increase of arterial stiffness thus augmenting myocardial damage. Sacubitril/Valsartan is used in the treatment of HF reduced ejection fraction (HFrEF) and has been proven effective in reducing cardiovascular disease (CVD)...
Autores principales: | Cassano, Velia, Armentaro, Giuseppe, Magurno, Marcello, Aiello, Vincenzo, Borrello, Francesco, Miceli, Sofia, Maio, Raffaele, Perticone, Maria, Marra, Alberto M., Cittadini, Antonio, Hribal, Marta L., Andreozzi, Francesco, Sesti, Giorgio, Sciacqua, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760824/ https://www.ncbi.nlm.nih.gov/pubmed/36545306 http://dx.doi.org/10.3389/fphar.2022.1069828 |
Ejemplares similares
-
Long Term Metabolic Effects of Sacubitril/Valsartan in Non-Diabetic and Diabetic Patients With Heart Failure Reduced Ejection Fraction: A Real Life Study
por: Armentaro, Giuseppe, et al.
Publicado: (2022) -
Uric Acid and Vascular Damage in Essential Hypertension: Role of Insulin Resistance
por: Cassano, Velia, et al.
Publicado: (2020) -
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study
por: Armentaro, Giuseppe, et al.
Publicado: (2021) -
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea
por: Pelaia, Corrado, et al.
Publicado: (2022) -
Oxidative Stress and Left Ventricular Performance in Patients with Different Glycometabolic Phenotypes
por: Cassano, Velia, et al.
Publicado: (2022)